Viewing StudyNCT06205498



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2025-12-17 @ 4:43 AM
Study NCT ID: NCT06205498
Status: None
Last Update Posted: 2025-08-22 00:00:00
First Post: 2023-07-06 00:00:00

Brief Title: Acalabrutinib Real World Italian obSErvational Study -ARISE
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-08-08
Start Date Type: ACTUAL
Primary Completion Date: 2025-01-08
Primary Completion Date Type: ACTUAL
Completion Date: 2025-01-08
Completion Date Type: ACTUAL
First Submit Date: 2023-07-06 00:00:00
First Submit QC Date: January 3 2024
Study First Post Date: 2024-01-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-21 00:00:00
Last Update Post Date: 2025-08-22 00:00:00
Last Update Post Date Type: ACTUAL